| no |
title |
author |
magazine |
year |
volume |
issue |
page(s) |
type |
| 1 |
Activin Receptor II Ligand Traps: New Treatment Paradigm for Low-Risk MDS
|
Komrokji, Rami S.
|
|
2019
|
14 |
4 |
p. 346-351
|
article
|
| 2 |
Considerations for the Treatment of Diffuse Large B Cell Lymphoma in the Elderly
|
Khan, Yasir
|
|
2019
|
14 |
4 |
p. 228-238
|
article
|
| 3 |
Emerging Role of Integrative Medicine in Hematologic Malignancies: a Literature Review and Update on Current Trends in Complementary Medical Practices in Hematologic Cancers
|
Okolo, Onyemaechi N.
|
|
2019
|
14 |
4 |
p. 328-336
|
article
|
| 4 |
Exploring a Future for PI3K Inhibitors in Chronic Lymphocytic Leukemia
|
Patel, Krish
|
|
2019
|
14 |
4 |
p. 292-301
|
article
|
| 5 |
Front-Line Treatment of High Grade B Cell Non-Hodgkin Lymphoma
|
Kesavan, Murali
|
|
2019
|
14 |
4 |
p. 207-218
|
article
|
| 6 |
Induced Pluripotent Stem Cell (iPSC)–Derived Lymphocytes for Adoptive Cell Immunotherapy: Recent Advances and Challenges
|
Nianias, Alexandros
|
|
2019
|
14 |
4 |
p. 261-268
|
article
|
| 7 |
Is There a Role for Dose Modification of TKI Therapy in CML?
|
Copland, M.
|
|
2019
|
14 |
4 |
p. 337-345
|
article
|
| 8 |
Mantle Cell Lymphoma: Which Patients Should We Transplant?
|
Gerson, James N.
|
|
2019
|
14 |
4 |
p. 239-246
|
article
|
| 9 |
Overcoming Challenges in Process Development of Cellular Therapies
|
Highfill, Steven L.
|
|
2019
|
14 |
4 |
p. 269-277
|
article
|
| 10 |
Pathogen-Specific T Cells Beyond CMV, EBV and Adenovirus
|
Jiang, Wei
|
|
|
14 |
4 |
p. 247-260
|
article
|
| 11 |
Pathogen-Specific T Cells Beyond CMV, EBV and Adenovirus
|
Jiang, Wei
|
|
2019
|
14 |
4 |
p. 247-260
|
article
|
| 12 |
Relevance of Prognostic Factors in the Era of Targeted Therapies in CLL
|
Kittai, Adam S.
|
|
2019
|
14 |
4 |
p. 302-309
|
article
|
| 13 |
Targeting Translation of mRNA as a Therapeutic Strategy in Cancer
|
Pal, Ipsita
|
|
2019
|
14 |
4 |
p. 219-227
|
article
|
| 14 |
The Rationale for Immunotherapy in Myeloproliferative Neoplasms
|
Masarova, Lucia
|
|
2019
|
14 |
4 |
p. 310-327
|
article
|
| 15 |
Towards Automated Manufacturing for Cell Therapies
|
Smith, David
|
|
2019
|
14 |
4 |
p. 278-285
|
article
|
| 16 |
Tumor-Infiltrating Lymphocytes in the Checkpoint Inhibitor Era
|
Linette, Gerald P.
|
|
2019
|
14 |
4 |
p. 286-291
|
article
|
Journal description